Clinical trial NCT00252525 - References

Type 2 Diabetes Mellitus — Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2

Citation(s)

•   Zimering MB, Anderson RJ, Ge L, Moritz TE, Duckworth WC; Investigators for the VADT
  Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the veterans affairs diabetes trial. Front Endocrinol (Lausanne). 2013 Nov
•   Zimering MB, Anderson RJ, Ge L, Moritz TE; Investigators for the VADT
  Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus. Metabolism. 2011 Feb;60(2):284-91. doi: 10.1016/j.metabol.2
•   Zimering MB, Anderson RJ, Luo P, Moritz TE; Investigators for the Veterans Affairs Diabetes Trial
  Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes Trial.
•   Zimering MB, Anderson RJ, Moritz TE, Ge L; Investigators for the VADT
  Endothelial cell inhibitory autoantibodies are associated with laser photocoagulation in adults from the Veterans Affairs Diabetes Trial. Metabolism. 2009 Jun;58(6):882-7. doi: 10.1016
•   Zimering MB, Anderson RJ, Moritz TE, Ge L; Investigators for the VADT
  Low plasma basic fibroblast growth factor is associated with laser photocoagulation treatment in adult type 2 diabetes mellitus from the Veterans Affairs Diabetes Trial. Metabolism. 20
•   Zimering MB, Moritz TE, Donnelly RJ
  Anti-neurotrophic effects from autoantibodies in adult diabetes having primary open angle glaucoma or dementia. Front Endocrinol (Lausanne). 2013 May 15;4:58. doi: 10.3389/fendo.2013.00058. eCollection 2013.
•   Zimering MB, Pan Z
  Autoantibodies in type 2 diabetes induce stress fiber formation and apoptosis in endothelial cells. J Clin Endocrinol Metab. 2009 Jun;94(6):2171-7. doi: 10.1210/jc.2008-2354. Epub 2009 Mar 17.

CSP #465B - Correlation of Plasma Endothelial Cell (Basic Fibroblast Growth Factor) Activity With Cardiovascular Events In Patients With Diabetes Mellitus Type 2

Details for clinical trial NCT00252525